Details
-
Bug
-
Resolution: Completed
-
Medium
-
None
-
None
-
None
-
IMDP Sprint 147, IMDP Sprint 148
-
Design
-
Design
-
Total of Gap $M in Safety stock should be adding up Gap$M of all phases.
Description
Gap $M Total value incorrect in Replenishmental Ideal and Safety Stock
Brand used for testing : 2-DESOXOPARAHERQUAMIDE 2/2-DESOXOPARAHERQUAMIDE 2 for the year 2025
Gap $M is 19.7 for FG and others Phases are 0. Hence Total value should 19.7. Total of Gap $M in Safety stock should be adding up Gap$M of all phases.
Same issue applies to the tab Replenishmental Ideal as well.
Same issue observed for the brand NIMENRIX/MENINGOCOCCAL A, C, Y, W-135 CONJUGATE VACCINE for the year 2023
